Viewing StudyNCT00002866



Ignite Creation Date: 2024-05-05 @ 10:17 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00002866
Status: COMPLETED
Last Update Posted: 2020-04-01
First Post: 1999-11-01

Brief Title: Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
Sponsor: NCIC Clinical Trials Group
Organization: Canadian Cancer Trials Group

Conditions & Keywords Data

Conditions:
Name
Neutropenia
Breast Cancer
Keywords:
Name View
neutropenia View
stage IV breast cancer View
recurrent breast cancer View